- 现金
- 62111 元
- 精华
- 26
- 帖子
- 30437
- 注册时间
- 2009-10-5
- 最后登录
- 2022-12-28
|
Clin Gastroenterol Hepatol. 2018 Oct 9. pii: S1542-3565(18)31090-5. doi: 10.1016/j.cgh.2018.10.007. [Epub ahead of print]
Management Algorithm for Interrupting Mother to Child Transmission of Hepatitis B Virus.
Hou J1, Cui F2, Ding Y3, Dou X3, Duan Z4, Han G5, Jia J6, Mao Q7, Li J8, Li Z9, Liu Z10, Wei L11, Xie Q12, Yang X9, Zhang H13, Zhuang H8.
Author information
1
Department of Infectious Diseases, Nanfang Hospital, Southern Medical University, Guangzhou, China. Electronic address: [email protected].
2
School of Public Health, Peking University, Beijing, China.
3
Department of Infectious Diseases, Shengjing Hospital, China Medical University, Shenyang, China.
4
Artificial Liver Center, Beijing Youan Hospital, Capital Medical University, Beijing, China.
5
Department of Gynecology and Obstetrics, The Second Affiliated Hospital of the Southeast University, Nanjing, China.
6
Liver Research Center, Beijing Friendship Hospital, Capital Medical University, Beijing, China.
7
Department of Infectious Diseases, Southwest Hospital, Army Medical University, Chongqing, China.
8
School of Basic Medical Sciences, Peking University Health Science Center, Beijing, China.
9
China Foundation for Hepatitis Prevention and Control, Beijing, China.
10
Department of Infectious Diseases, Nanfang Hospital, Southern Medical University, Guangzhou, China.
11
Peking University Hepatology Institute, Peking University People's Hospital, Beijing, China.
12
Department of Infectious Diseases, Ruijin Hospital, Shanghai, China.
13
Department of Gynecology and Obstetrics, Beijing Youan Hospital, Capital Medical University, Beijing, China.
Abstract
In areas where hepatitis B virus (HBV) is endemic, mother to child transmission (MTCT) is the major route of infection of children. Blocking MTCT of HBV would therefore reduce its prevalence. The China Foundation of Hepatitis Prevention and Control organized a team of specialists in infectious diseases, hepatology, immunology, obstetrics, and public health to develop an algorithm for interrupting MTCT of HBV, based on the most recent hepatitis B guidelines and latest evidence. This algorithm comprises 10 steps and has been adopted in clinical practice in China. Four aspects (screening, antiviral intervention during pregnancy, immunoprophylaxis, and post-vaccination serologic testing) are the core components of preventing MTCT. Although the combination of passive and active immunization in newborns of HBsAg-positive mothers reduces MTCT of HBV, this immunoprophylaxis cannot completely eradicate MTCT. In the past decade, administration of antiviral agents to pregnant women has been shown to be safe and effective in reducing MTCT of HBV in combination with immunoprophylaxis. Aiming to achieve zero MTCT, this algorithm recommends the use of antivirals during pregnancy by women with high viral loads. Preventing MTCT is key to achieving the goal of eliminating HBV as a public health threat by 2030. Implementation and enhancement of the standardized algorithm for pregnant women with chronic HBV infection and their infants is urgently needed to prevent MTCT.
KEYWORDS:
CFHPC; antiviral therapy; neonate; vaccine
PMID:
30312789
DOI:
10.1016/j.cgh.2018.10.007
|
|